LISA PANITZ: Open Payments
NPI 1336517077 · LUTHERVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 61 payments from 16 companies in 2025. Trend: 2023 $1,297 · 2024 $1,088 · 2025 $1,229
Food & beverage: $1,229
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $275 |
| ABBVIE INC. | 9 | $183 |
| Lilly USA, LLC | 9 | $147 |
| Exact Sciences Corporation | 5 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| PFIZER INC. | 4 | $79 |
| Amgen Inc. | 3 | $70 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $40 |
Products named: Rybelsus, MOUNJARO, VRAYLAR, Cologuard Collection Kit, Ozempic, QULIPTA, GEMTESA, PREVNAR 20.
Industry payments across MD — which companies pay providers there.
